Pfizer, J&J See Promise, Make Investment in Cancer Device Company
This article was originally published in Start Up
Pfizer's venture group invested alongside Johnson & Johnson Development Corp. and Index Ventures in NovoCure Ltd., a device company developing a treatment to bolster the affect of chemotherapies.
You may also be interested in...
Fred Hassan's days as chairman of Schering-Plough are numbered, and he hasn't indicated his next step once his company's merger with Merck closes, likely later this year. He remained cagey - giving only a few indirect clues about his preferences in an interview held Sept. 23 as part of Windhover's Pharmaceutical Strategic Alliances conference in New York City
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.